Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg".
Press Release Feb 04 2026
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 23 2026
- Press Release Jan 22 2026
- Press Release Jan 15 2026
- Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
- Press Release Jan 13 2026
Later from Zydus Lifesciences
- Press Release Feb 06 2026
- Press Release Feb 09 2026
- Press Release 10-02-2026 NewspaperPublication10022026
- Zydus Lifesciences Limited Press Release Feb 14 2026
- Zydus Lifesciences Limited Press Release Feb 17 2026
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences